The inhibition of breast tumor growth by NP/PTX/siCD47/R848 may be achieved by increasing the proportion of CD8+ T cells in the tumor microenvironment and promoting their activation; Simultaneously reducing the proportion of Treg and MDSC weakens the immunosuppressive microenvironment. Here, CD8A is linked to neoplasm.